Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.2 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.68.
Market Cap
8.2T
Revenue
4.59T
Profits
201.51B
PE Ratio
40.68
Profit Margin
4.39%
Dividend Yield
0.44%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 961.99B | 1.37% | 2,654,494 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 537.39B | 0.16% | 6,503,978 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 383.62B | 0.80% | 5,665,940 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 343.21B | -0.24% | 6,833,749 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 283.29B | -0.82% | 8,224,541 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 275.27B | -0.66% | 2,396,483 | 60.44B |
| 7 | NVS | Novartis AG | 262.89B | 0.13% | 1,537,782 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 187.14B | -2.14% | 11,332,056 | 50.57B |
| 9 | AMGN | Amgen Inc. | 182.54B | 3.03% | 2,286,032 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 176.13B | -1.69% | 1,937,330 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 160.15B | 1.11% | 6,231,802 | 29.74B |
| 12 | ABT | Abbott Laboratories | 151.52B | 0.02% | 10,443,425 | 45.13B |
| 13 | PFE | Pfizer Inc. | 144.42B | -0.82% | 30,932,982 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 144.25B | 1.24% | 2,647,836 | 10.58B |
| 15 | DHR | Danaher Corporation | 126.04B | 1.12% | 2,907,880 | 24.78B |
| 16 | CVS | CVS Health Corporation | 116.58B | 2.09% | 7,564,746 | 405.62B |
| 17 | SYK | Stryker Corporation | 113.09B | 0.58% | 2,188,471 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 111.74B | 0.48% | 11,535,427 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 108.72B | 0.76% | 1,573,591 | 12.22B |
| 20 | SNY | Sanofi | 102.43B | -1.00% | 2,471,928 | 54.60B |
| 21 | MDT | Medtronic plc | 100.08B | 5.69% | 20,284,124 | 36.36B |
| 22 | GSK | GSK plc | 99.30B | 1.47% | 3,808,805 | 43.29B |
| 23 | MCK | McKesson Corporation | 88.89B | 0.37% | 786,355 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 84.97B | 0.58% | 1,483,362 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 80.58B | -1.12% | 2,210,838 | 76.39B |
| 26 | CI | The Cigna Group | 71.62B | -0.73% | 1,376,607 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 70.88B | 0.02% | 24,653,635 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.97B | 2.66% | 984,965 | 14.92B |
| 29 | COR | Cencora, Inc. | 51.29B | -0.45% | 1,591,606 | 328.68B |
| 30 | ARGX | argenx SE | 50.20B | 1.37% | 314,187 | 4.74B |
| 31 | EW | Edwards Lifesciences Corporation | 49.52B | -1.89% | 4,964,447 | 6.30B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 46.89B | -0.99% | 3,767,924 | 28.34B |
| 33 | CAH | Cardinal Health, Inc. | 45.87B | 0.50% | 1,212,366 | 250.74B |
| 34 | MDLN | Medline Inc. | 45.28B | 3.86% | 15,566,652 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.23B | 1.80% | 891,192 | 4.45B |
| 36 | BDX | Becton, Dickinson and Company | 40.12B | 0.82% | 1,609,383 | 22.23B |
| 37 | HUM | Humana Inc. | 39.32B | 2.08% | 1,124,906 | 137.20B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.06B | 2.26% | 988,504 | 4.29B |
| 39 | A | Agilent Technologies, Inc. | 38.81B | 1.74% | 2,922,671 | 7.23B |
| 40 | HLN | Haleon plc | 38.23B | 0.23% | 6,602,367 | 14.85B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 38.23B | -0.76% | 5,069,130 | 17.35B |
| 42 | WAT | Waters Corporation | 37.29B | 2.11% | 920,081 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 33.16B | 3.09% | 2,006,287 | - |
| 44 | ZTS | Zoetis Inc. | 32.53B | 1.57% | 8,097,680 | 9.53B |
| 45 | RPRX | Royalty Pharma plc | 31.65B | 1.78% | 4,462,732 | 2.44B |
| 46 | ALC | Alcon Inc. | 31.50B | -0.09% | 2,571,776 | 10.63B |
| 47 | ONC | BeOne Medicines AG | 31.02B | 1.57% | 206,640 | 5.70B |
| 48 | IQV | IQVIA Holdings Inc. | 30.38B | 0.78% | 1,561,054 | 16.63B |
| 49 | NTRA | Natera, Inc. | 30.34B | -0.41% | 1,459,727 | 2.50B |
| 50 | CNC | Centene Corporation | 29.41B | -0.73% | 3,920,835 | 178.33B |
| 51 | VEEV | Veeva Systems Inc. | 29.17B | -2.31% | 4,455,226 | 3.32B |
| 52 | BIIB | Biogen Inc. | 28.93B | 3.78% | 891,154 | 9.94B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.22B | 0.06% | 4,291,703 | 20.98B |
| 54 | DXCM | DexCom, Inc. | 28.08B | -0.93% | 4,051,656 | 4.82B |
| 55 | RMD | ResMed Inc. | 27.05B | 1.99% | 1,683,729 | 5.54B |
| 56 | ILMN | Illumina, Inc. | 25.86B | 5.16% | 3,139,572 | 4.39B |
| 57 | PHG | Koninklijke Philips N.V. | 24.17B | -0.31% | 919,304 | 20.34B |
| 58 | MTD | Mettler-Toledo International Inc. | 23.63B | -0.06% | 229,071 | 4.09B |
| 59 | UTHR | United Therapeutics Corporation | 23.32B | 1.74% | 326,018 | 3.17B |
| 60 | INSM | Insmed Incorporated | 22.51B | 0.13% | 2,977,964 | 819.56M |
| 61 | BNTX | BioNTech SE | 22.37B | -0.77% | 659,703 | 3.23B |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.35B | 1.33% | 635,113 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.44B | 0.26% | 647,960 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 21.23B | 0.47% | 679,745 | 14.14B |
| 65 | ROIV | Roivant Sciences Ltd. | 20.64B | 1.59% | 3,612,149 | 8.26M |
| 66 | STE | STERIS plc | 20.52B | 0.20% | 856,285 | 5.94B |
| 67 | INCY | Incyte Corporation | 19.57B | 6.22% | 2,268,511 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 19.47B | 7.49% | 6,923,208 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.12B | -0.83% | 6,969,629 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 16.84B | -2.41% | 2,111,566 | 1.08B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 16.60B | 6.63% | 1,939,476 | 3.10B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.44B | 1.47% | 1,947,106 | 8.41B |
| 73 | GMAB | Genmab A/S | 14.53B | 0.13% | 1,376,889 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 14.49B | 2.13% | 910,224 | 4.44B |
| 75 | THC | Tenet Healthcare Corporation | 14.20B | 0.76% | 2,455,069 | 21.46B |
| 76 | SOLV | Solventum Corporation | 13.57B | 2.53% | 1,793,249 | 8.26B |
| 77 | ASND | Ascendis Pharma A/S | 13.47B | 0.09% | 379,385 | 998.25M |
| 78 | EXEL | Exelixis, Inc. | 12.97B | 6.30% | 2,977,963 | 2.38B |
| 79 | MEDP | Medpace Holdings, Inc. | 12.88B | 1.17% | 239,229 | 2.68B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 12.82B | 2.50% | 2,740,908 | 579.96M |
| 81 | SNN | Smith & Nephew plc | 12.72B | 1.94% | 1,381,835 | 6.16B |
| 82 | PEN | Penumbra, Inc. | 12.56B | 0.20% | 402,588 | 1.45B |
| 83 | DVA | DaVita Inc. | 12.52B | 3.80% | 735,505 | 13.84B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 12.52B | 2.60% | 1,826,094 | 13.65B |
| 85 | ELAN | Elanco Animal Health Incorporated | 12.27B | 3.98% | 8,114,474 | 4.89B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.20B | 1.16% | 1,303,152 | 1.06B |
| 87 | AXSM | Axsome Therapeutics, Inc. | 12.02B | 5.10% | 783,541 | 708.24M |
| 88 | COO | The Cooper Companies, Inc. | 11.77B | 1.43% | 4,000,768 | 4.15B |
| 89 | RGC | Regencell Bioscience Holdings Limited | 11.77B | 2.59% | 95,492 | - |
| 90 | SMMT | Summit Therapeutics Inc. | 11.70B | 1.41% | 4,371,504 | - |
| 91 | ALGN | Align Technology, Inc. | 11.58B | -2.99% | 1,068,651 | 4.10B |
| 92 | RVTY | Revvity, Inc. | 11.28B | 0.68% | 1,152,451 | 2.90B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.25B | 7.79% | 264,446 | 1.13B |
| 94 | FMS | Fresenius Medical Care AG | 11.23B | 1.70% | 980,281 | 22.32B |
| 95 | ICLR | ICON Public Limited Company | 11.02B | 4.62% | 1,380,199 | 8.25B |
| 96 | RDY | Dr. Reddy's Laboratories Limited | 10.98B | -0.08% | 1,339,830 | 3.58B |
| 97 | GMED | Globus Medical, Inc. | 10.58B | -0.38% | 1,619,083 | 3.10B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.56B | 2.51% | 2,266,873 | 3.24B |
| 99 | EHC | Encompass Health Corporation | 10.23B | 1.60% | 699,402 | 6.07B |
| 100 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.22B | 2.44% | 1,484,143 | 622.01M |
| 101 | PODD | Insulet Corporation | 9.93B | 0.61% | 1,140,705 | 2.90B |
| 102 | ENSG | The Ensign Group, Inc. | 9.66B | 0.59% | 574,783 | 5.27B |
| 103 | MOH | Molina Healthcare, Inc. | 9.63B | 2.76% | 793,182 | 43.10B |
| 104 | CYTK | Cytokinetics, Incorporated | 9.60B | -0.28% | 1,594,303 | 105.82M |
| 105 | BAX | Baxter International Inc. | 9.58B | -0.75% | 4,587,986 | 11.32B |
| 106 | BRKR | Bruker Corporation | 9.54B | 9.40% | 4,416,170 | 3.46B |
| 107 | MASI | Masimo Corporation | 9.36B | 0.03% | 844,094 | 1.56B |
| 108 | KRYS | Krystal Biotech, Inc. | 8.90B | 2.94% | 240,361 | 417.30M |
| 109 | UHS | Universal Health Services, Inc. | 8.84B | 2.41% | 1,405,090 | 17.76B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.66B | 2.91% | 535,743 | 4.03B |
| 111 | HSIC | Henry Schein, Inc. | 8.63B | -0.39% | 1,155,802 | 13.38B |
| 112 | TEM | Tempus AI, Inc. | 8.53B | -4.25% | 6,467,146 | 1.36B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 8.28B | 5.34% | 2,144,430 | 1.51B |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 8.16B | -0.42% | 327,309 | 2.59B |
| 115 | TECH | Bio-Techne Corporation | 7.96B | 2.17% | 2,222,272 | 1.21B |
| 116 | CORT | Corcept Therapeutics Incorporated | 7.80B | 2.04% | 788,819 | 769.10M |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 7.78B | 8.08% | 676,327 | 7.46M |
| 118 | QGEN | Qiagen N.V. | 7.54B | 2.13% | 3,247,747 | 2.10B |
| 119 | IBRX | ImmunityBio, Inc. | 7.52B | -0.69% | 8,966,066 | 140.98M |
| 120 | ATR | AptarGroup, Inc. | 7.18B | 0.31% | 372,406 | 3.87B |
| 121 | ALKS | Alkermes plc | 7.13B | 3.48% | 2,000,145 | 1.56B |
| 122 | NUVL | Nuvalent, Inc. | 7.12B | -1.28% | 1,475,441 | - |
| 123 | HQY | HealthEquity, Inc. | 7.12B | -3.54% | 940,658 | 1.34B |
| 124 | RGEN | Repligen Corporation | 6.87B | 0.50% | 662,836 | 763.34M |
| 125 | PCVX | Vaxcyte, Inc. | 6.78B | -1.01% | 1,508,210 | - |
| 126 | LEGN | Legend Biotech Corporation | 6.68B | -0.83% | 4,086,869 | 1.14B |
| 127 | GKOS | Glaukos Corporation | 6.67B | 2.58% | 1,095,239 | 551.35M |
| 128 | ABVX | ABIVAX Société Anonyme | 6.59B | 24.34% | 7,165,138 | 5.67M |
| 129 | LNTH | Lantheus Holdings, Inc. | 6.53B | 4.10% | 1,081,769 | 1.55B |
| 130 | IMVT | Immunovant, Inc. | 6.40B | 0.74% | 1,861,076 | - |
| 131 | SYRE | Spyre Therapeutics, Inc. | 6.38B | 6.30% | 1,720,072 | - |
| 132 | HIMS | Hims & Hers Health, Inc. | 6.37B | - | 13,787,752 | 2.37B |
| 133 | GRFS | Grifols, S.A. | 6.33B | -2.10% | 474,358 | 8.58B |
| 134 | APGE | Apogee Therapeutics, Inc. | 6.31B | 6.96% | 1,126,234 | - |
| 135 | AVTR | Avantor, Inc. | 6.19B | 0.89% | 6,708,113 | 6.55B |
| 136 | OSCR | Oscar Health, Inc. | 6.17B | -3.03% | 6,677,506 | 13.30B |
| 137 | CNTA | Centessa Pharmaceuticals plc | 6.17B | -0.13% | 840,514 | 15.00M |
| 138 | PTGX | Protagonist Therapeutics, Inc. | 6.14B | 2.34% | 576,264 | 74.06M |
| 139 | KYMR | Kymera Therapeutics, Inc. | 6.02B | 2.69% | 859,442 | 51.48M |
| 140 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.81B | 0.43% | 416,055 | 217.17M |
| 141 | PACS | PACS Group, Inc. | 5.78B | -1.11% | 575,729 | 5.43B |
| 142 | PTCT | PTC Therapeutics, Inc. | 5.70B | 0.66% | 1,124,822 | 827.11M |
| 143 | TFX | Teleflex Incorporated | 5.69B | 2.65% | 659,089 | 2.13B |
| 144 | TGTX | TG Therapeutics, Inc. | 5.68B | 9.47% | 3,656,111 | 700.35M |
| 145 | CHE | Chemed Corporation | 5.64B | 2.31% | 266,642 | 2.54B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 5.60B | -0.24% | 619,604 | 569.61M |
| 147 | COGT | Cogent Biosciences, Inc. | 5.51B | -1.53% | 2,471,509 | - |
| 148 | BLTE | Belite Bio, Inc | 5.40B | 1.70% | 165,830 | - |
| 149 | SRRK | Scholar Rock Holding Corporation | 5.35B | -0.09% | 1,122,755 | - |
| 150 | BLCO | Bausch + Lomb Corporation | 5.30B | -0.73% | 1,106,098 | 5.21B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.17B | 2.18% | 1,706,334 | 7.50M |
| 152 | STVN | Stevanato Group S.p.A. | 5.06B | -1.38% | 474,207 | 1.39B |
| 153 | CRSP | CRISPR Therapeutics AG | 5.02B | 0.12% | 1,270,381 | 4.10M |
| 154 | LQDA | Liquidia Corporation | 4.95B | 1.05% | 1,392,904 | 288.07M |
| 155 | CGON | CG Oncology, Inc. | 4.80B | -2.00% | 964,829 | 5.07M |
| 156 | LGND | Ligand Pharmaceuticals Incorporated | 4.70B | 0.70% | 157,008 | 274.48M |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.64B | 4.17% | 580,462 | 1.34M |
| 158 | HNGE | Hinge Health, Inc. | 4.54B | 0.31% | 998,772 | 646.34M |
| 159 | BLLN | BillionToOne, Inc. | 4.52B | 4.36% | 976,863 | 354.54M |
| 160 | TWST | Twist Bioscience Corporation | 4.50B | 3.11% | 1,429,831 | 409.48M |
| 161 | CAI | Caris Life Sciences, Inc. | 4.38B | -6.30% | 2,807,589 | 907.29M |
| 162 | SHC | Sotera Health Company | 4.35B | 1.66% | 2,480,398 | 1.19B |
| 163 | CELC | Celcuity Inc. | 4.34B | -2.70% | 5,473,139 | - |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 4.11B | 1.78% | 1,203,757 | 3.05B |
| 165 | ERAS | Erasca, Inc. | 4.10B | -2.23% | 4,620,361 | - |
| 166 | TXG | 10x Genomics, Inc. | 4.08B | 4.72% | 3,378,590 | 638.78M |
| 167 | RDNT | RadNet, Inc. | 4.08B | -4.49% | 636,799 | 2.14B |
| 168 | MANE | Veradermics, Incorporated | 4.04B | -1.47% | 579,118 | - |
| 169 | MMED | MiniMed Group, Inc. | 4.00B | 15.93% | 2,961,639 | 3.10B |
| 170 | TVTX | Travere Therapeutics, Inc. | 3.99B | 5.21% | 1,769,272 | 536.20M |
| 171 | LIVN | LivaNova PLC | 3.92B | -2.73% | 727,511 | 1.43B |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 3.90B | -2.79% | 1,444,139 | - |
| 173 | VCYT | Veracyte, Inc. | 3.89B | 1.86% | 1,451,590 | 541.74M |
| 174 | DOCS | Doximity, Inc. | 3.85B | -2.19% | 2,588,301 | 644.86M |
| 175 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.03% | 1,682,037 | 596.96M |
| 176 | NAMS | NewAmsterdam Pharma Company N.V. | 3.75B | 1.26% | 1,698,464 | 22.57M |
| 177 | WAY | Waystar Holding Corp. | 3.75B | -6.22% | 2,449,418 | 1.16B |
| 178 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.68B | 1.98% | 495,709 | 754.05M |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.67B | 2.58% | 1,282,122 | 1.10B |
| 180 | NVST | Envista Holdings Corporation | 3.65B | -2.35% | 2,501,434 | 2.81B |
| 181 | MMSI | Merit Medical Systems, Inc. | 3.62B | -0.39% | 663,277 | 1.54B |
| 182 | OGN | Organon & Co. | 3.52B | 0.15% | 2,566,475 | 6.16B |
| 183 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.49B | 1.47% | 857,809 | 18.07M |
| 184 | ORKA | Oruka Therapeutics, Inc. | 3.45B | 3.57% | 829,892 | - |
| 185 | IRTC | iRhythm Holdings, Inc. | 3.44B | -0.89% | 656,876 | 787.85M |
| 186 | VKTX | Viking Therapeutics, Inc. | 3.41B | 0.14% | 1,467,027 | - |
| 187 | RLAY | Relay Therapeutics, Inc. | 3.33B | -2.55% | 3,723,609 | 10.68M |
| 188 | ICUI | ICU Medical, Inc. | 3.27B | 0.19% | 224,567 | 2.16B |
| 189 | OPCH | Option Care Health, Inc. | 3.22B | -0.05% | 2,544,181 | 5.67B |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.17B | -1.36% | 662,070 | 2.23B |
| 191 | DNLI | Denali Therapeutics Inc. | 3.12B | 1.60% | 1,026,795 | - |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.11B | -0.14% | 1,327,036 | 56.99M |
| 193 | ITGR | Integer Holdings Corporation | 3.09B | 0.64% | 564,432 | 1.86B |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.00B | -2.49% | 956,218 | 236.00M |
| 195 | HAE | Haemonetics Corporation | 2.99B | -0.74% | 743,578 | 1.33B |
| 196 | DYN | Dyne Therapeutics, Inc. | 2.97B | 4.35% | 1,556,601 | - |
| 197 | WRBY | Warby Parker Inc. | 2.97B | -3.47% | 2,171,036 | 890.57M |
| 198 | TLX | Telix Pharmaceuticals Limited | 2.96B | -4.26% | 251,284 | 803.79M |
| 199 | ALHC | Alignment Healthcare, Inc. | 2.95B | 4.47% | 9,999,730 | 4.26B |
| 200 | BEAM | Beam Therapeutics Inc. | 2.94B | 2.04% | 1,154,272 | 164.01M |
| 201 | BKD | Brookdale Senior Living Inc. | 2.92B | 1.66% | 3,803,773 | 3.00B |
| 202 | NHC | National HealthCare Corporation | 2.91B | 1.69% | 116,422 | 1.53B |
| 203 | LFST | LifeStance Health Group, Inc. | 2.91B | -3.35% | 1,961,688 | 1.49B |
| 204 | KLRA | Kailera Therapeutics, Inc. | 2.90B | -0.93% | 422,318 | - |
| 205 | IRON | Disc Medicine, Inc. | 2.69B | 3.46% | 333,608 | - |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 2.67B | 2.69% | 1,035,584 | 415.62M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.67B | 0.83% | 473,039 | - |
| 208 | GRAL | GRAIL, Inc. | 2.62B | 2.05% | 799,065 | 156.12M |
| 209 | PRVA | Privia Health Group, Inc. | 2.60B | -0.67% | 908,366 | 2.25B |
| 210 | DFTX | Definium Therapeutics, Inc. | 2.57B | 3.19% | 2,290,543 | - |
| 211 | ALMS | Alumis Inc. | 2.56B | 0.20% | 1,153,605 | 8.40M |
| 212 | ADPT | Adaptive Biotechnologies Corporation | 2.56B | 5.61% | 2,232,909 | 295.41M |
| 213 | SUPN | Supernus Pharmaceuticals, Inc. | 2.56B | -0.08% | 983,282 | 776.83M |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 2.53B | 2.25% | 461,522 | 535.08M |
| 215 | IDYA | IDEAYA Biosciences, Inc. | 2.50B | 1.90% | 1,067,242 | 225.27M |
| 216 | HTFL | HeartFlow, Inc. | 2.49B | -2.37% | 1,310,783 | 191.42M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.48B | 0.57% | 349,077 | 1.46B |
| 218 | GMRS | GMR Solutions Inc. | 2.42B | 2.26% | 723,094 | 5.74B |
| 219 | TMDX | TransMedics Group, Inc. | 2.41B | 1.81% | 1,167,799 | 635.89M |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.37B | 5.36% | 3,127,514 | 3.37B |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.34B | 3.01% | 875,859 | 865.00K |
| 222 | VERA | Vera Therapeutics, Inc. | 2.24B | 0.03% | 989,794 | - |
| 223 | IMNM | Immunome, Inc. | 2.24B | 2.43% | 1,245,959 | 4.02M |
| 224 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | 2.89% | 1,798,371 | 670.00M |
| 225 | ELVN | Enliven Therapeutics, Inc. | 2.19B | 1.44% | 695,923 | - |
| 226 | AXGN | Axogen, Inc. | 2.16B | 2.97% | 574,605 | 238.11M |
| 227 | PBH | Prestige Consumer Healthcare Inc. | 2.15B | -0.85% | 619,654 | 1.09B |
| 228 | ESTA | Establishment Labs Holdings Inc. | 2.13B | 2.84% | 278,207 | 229.58M |
| 229 | KOD | Kodiak Sciences Inc. | 2.11B | 1.96% | 928,316 | - |
| 230 | PHVS | Pharvaris N.V. | 2.10B | 4.00% | 703,635 | - |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.10B | -1.08% | 4,229,157 | 885.72M |
| 232 | LMAT | LeMaitre Vascular, Inc. | 2.09B | 0.02% | 212,643 | 256.28M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.07B | -13.14% | 8,178,104 | - |
| 234 | SEM | Select Medical Holdings Corporation | 2.05B | - | 1,438,615 | 5.52B |
| 235 | HCM | HUTCHMED (China) Limited | 2.02B | -1.82% | 98,631 | 548.51M |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 1.82% | 1,692,248 | 298.30M |
| 237 | NKTR | Nektar Therapeutics | 2.00B | 1.14% | 920,798 | 55.63M |
| 238 | PGNY | Progyny, Inc. | 1.96B | -0.52% | 1,402,079 | 1.29B |
| 239 | XRAY | DENTSPLY SIRONA Inc. | 1.93B | -1.93% | 3,614,794 | 3.68B |
| 240 | ZLAB | Zai Lab Limited | 1.93B | 0.12% | 584,341 | 453.28M |
| 241 | CLOV | Clover Health Investments, Corp. | 1.92B | -2.14% | 6,964,092 | 2.21B |
| 242 | NEOG | Neogen Corporation | 1.92B | 0.69% | 2,014,245 | 870.56M |
| 243 | TRVI | Trevi Therapeutics, Inc. | 1.91B | -0.37% | 720,408 | - |
| 244 | OMCL | Omnicell, Inc. | 1.91B | -0.07% | 539,853 | 1.23B |
| 245 | QURE | uniQure N.V. | 1.88B | 11.66% | 2,938,513 | 18.09M |
| 246 | NVCR | NovoCure Limited | 1.87B | 2.09% | 1,696,006 | 674.41M |
| 247 | MESO | Mesoblast Limited | 1.87B | - | 108,606 | 65.38M |
| 248 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | 3.85% | 1,008,662 | 899.11M |
| 249 | BHC | Bausch Health Companies Inc. | 1.85B | -1.20% | 2,580,009 | 10.53B |
| 250 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | -3.88% | 18,484,472 | 66.41M |
| 251 | STOK | Stoke Therapeutics, Inc. | 1.83B | 2.72% | 449,722 | 32.08M |
| 252 | OCUL | Ocular Therapeutix, Inc. | 1.83B | 0.48% | 2,044,732 | 52.04M |
| 253 | ASTH | Astrana Health, Inc. | 1.82B | -0.57% | 338,303 | 3.53B |
| 254 | NTLA | Intellia Therapeutics, Inc. | 1.82B | -0.84% | 3,092,471 | 66.09M |
| 255 | VRDN | Viridian Therapeutics, Inc. | 1.81B | 3.02% | 1,685,743 | 70.92M |
| 256 | CMPS | COMPASS Pathways plc | 1.80B | -4.80% | 3,207,803 | - |
| 257 | ADMA | ADMA Biologics, Inc. | 1.80B | 2.11% | 2,919,452 | 509.86M |
| 258 | LKFT | Lakefront Biotherapeutics NV | 1.79B | 0.75% | 404,597 | 1.20B |
| 259 | ZYME | Zymeworks Inc. | 1.78B | 1.00% | 526,822 | 81.26M |
| 260 | NBTX | Nanobiotix S.A. | 1.77B | -4.24% | 49,188 | 38.27M |
| 261 | VCEL | Vericel Corporation | 1.77B | 0.84% | 599,416 | 292.09M |
| 262 | RAPP | Rapport Therapeutics, Inc. | 1.77B | 6.02% | 198,496 | 20.00M |
| 263 | MD | Pediatrix Medical Group, Inc. | 1.75B | 0.37% | 681,696 | 1.93B |
| 264 | SGRY | Surgery Partners, Inc. | 1.75B | -1.89% | 1,412,035 | 3.34B |
| 265 | ABCL | AbCellera Biologics Inc. | 1.75B | -6.69% | 7,077,133 | 79.21M |
| 266 | PLSE | Pulse Biosciences, Inc. | 1.73B | 2.92% | 261,443 | 751.00K |
| 267 | SRPT | Sarepta Therapeutics, Inc. | 1.71B | -0.06% | 3,538,175 | 2.18B |
| 268 | TYRA | Tyra Biosciences, Inc. | 1.71B | 0.10% | 769,598 | - |
| 269 | IOVA | Iovance Biotherapeutics, Inc. | 1.69B | -7.56% | 9,665,314 | 285.61M |
| 270 | UFPT | UFP Technologies, Inc. | 1.69B | 0.83% | 207,561 | 608.85M |
| 271 | NVAX | Novavax, Inc. | 1.68B | -0.10% | 3,088,277 | 596.34M |
| 272 | GHRS | GH Research PLC | 1.68B | -1.77% | 141,097 | - |
| 273 | AAPG | Ascentage Pharma Group International | 1.66B | -3.14% | 22,574 | 82.08M |
| 274 | ATAI | AtaiBeckley Inc. | 1.66B | -5.82% | 4,834,840 | 3.49M |
| 275 | SION | Sionna Therapeutics, Inc. | 1.66B | 0.60% | 319,272 | - |
| 276 | PVLA | Palvella Therapeutics, Inc. | 1.66B | 10.27% | 571,111 | - |
| 277 | GENB | Generate Biomedicines, Inc. | 1.65B | 7.85% | 762,099 | 30.30M |
| 278 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | 4.41% | 679,110 | 66.05M |
| 279 | NUVB | Nuvation Bio Inc. | 1.64B | -3.67% | 3,230,165 | 143.05M |
| 280 | BHVN | Biohaven Ltd. | 1.63B | 6.71% | 3,113,823 | - |
| 281 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | -0.27% | 1,249,263 | 217.17M |
| 282 | ADUS | Addus HomeCare Corporation | 1.62B | -2.17% | 242,772 | 1.45B |
| 283 | INVA | Innoviva, Inc. | 1.60B | 1.64% | 909,630 | 420.69M |
| 284 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -5.44% | 1,325,609 | 71.78M |
| 285 | CAPR | Capricor Therapeutics, Inc. | 1.60B | 1.10% | 664,782 | 11.13M |
| 286 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | 0.78% | 257,433 | 923.71M |
| 287 | TSHA | Taysha Gene Therapies, Inc. | 1.59B | -2.46% | 1,653,227 | 7.47M |
| 288 | WGS | GeneDx Holdings Corp. | 1.57B | -0.21% | 1,081,495 | 442.68M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.57B | -0.09% | 604,395 | 367.34M |
| 290 | SLS | SELLAS Life Sciences Group, Inc. | 1.52B | -1.68% | 7,536,464 | - |
| 291 | PRCT | PROCEPT BioRobotics Corporation | 1.50B | -1.61% | 732,704 | 322.02M |
| 292 | ANAB | AnaptysBio, Inc. | 1.49B | -0.04% | 931,420 | 232.39M |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.49B | -0.85% | 881,789 | 42.95M |
| 294 | VIR | Vir Biotechnology, Inc. | 1.48B | 0.34% | 2,373,779 | 65.50M |
| 295 | FTRE | Fortrea Holdings Inc. | 1.48B | 1.76% | 1,021,507 | 2.71B |
| 296 | AVAH | Aveanna Healthcare Holdings Inc. | 1.48B | 4.79% | 2,741,062 | 2.52B |
| 297 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.47B | -0.68% | 1,026,740 | -665.00K |
| 298 | IMCR | Immunocore Holdings plc | 1.46B | -3.11% | 647,831 | 412.81M |
| 299 | ALMR | Alamar Biosciences, Inc. | 1.45B | 0.67% | 145,320 | 87.16M |
| 300 | PRGO | Perrigo Company plc | 1.45B | - | 2,338,194 | 4.18B |
| 301 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.04% | 6,431,828 | 114.48M |
| 302 | MBX | MBX Biosciences, Inc. | 1.43B | -2.12% | 466,094 | - |
| 303 | STAA | STAAR Surgical Company | 1.41B | -0.81% | 395,493 | 290.38M |
| 304 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 1.70% | 327,721 | 1.30M |
| 305 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -0.47% | 712,108 | - |
| 306 | HCSG | Healthcare Services Group, Inc. | 1.39B | -0.25% | 637,914 | 1.85B |
| 307 | SEPN | Septerna, Inc. | 1.38B | 2.30% | 286,521 | 72.26M |
| 308 | AGL | agilon health, inc. | 1.38B | -4.67% | 252,751 | 5.82B |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.38B | 2.35% | 412,555 | 20.00M |
| 310 | DMRA | Damora Therapeutics, Inc. | 1.37B | -2.70% | 318,652 | - |
| 311 | IMTX | Immatics N.V. | 1.37B | 1.64% | 546,590 | 43.00M |
| 312 | PGEN | Precigen, Inc. | 1.36B | -1.30% | 7,789,044 | 31.60M |
| 313 | MLTX | MoonLake Immunotherapeutics | 1.34B | 2.24% | 570,162 | - |
| 314 | ARDX | Ardelyx, Inc. | 1.34B | -1.81% | 3,818,081 | 427.68M |
| 315 | SVRA | Savara Inc. | 1.33B | - | 1,806,058 | - |
| 316 | BLFS | BioLife Solutions, Inc. | 1.33B | -0.87% | 847,098 | 101.66M |
| 317 | ATRC | AtriCure, Inc. | 1.33B | 1.35% | 592,175 | 552.16M |
| 318 | NEO | NeoGenomics, Inc. | 1.32B | 0.20% | 1,280,504 | 745.97M |
| 319 | BCAX | Bicara Therapeutics Inc. | 1.31B | 1.83% | 548,306 | - |
| 320 | URGN | UroGen Pharma Ltd. | 1.30B | 0.23% | 488,773 | 140.49M |
| 321 | AHCO | AdaptHealth Corp. | 1.29B | 0.73% | 1,526,223 | 3.29B |
| 322 | PAHC | Phibro Animal Health Corporation | 1.29B | 11.94% | 635,773 | 1.50B |
| 323 | MPLT | MapLight Therapeutics, Inc. | 1.29B | 3.66% | 193,138 | - |
| 324 | TDOC | Teladoc Health, Inc. | 1.28B | -5.97% | 4,972,199 | 2.51B |
| 325 | IART | Integra LifeSciences Holdings Corporation | 1.25B | 2.74% | 766,055 | 1.64B |
| 326 | NNNN | Anbio Biotechnology | 1.25B | -11.24% | 42,451 | 8.65M |
| 327 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.25B | 0.21% | 4,933,674 | 204.73M |
| 328 | AHG | Akso Health Group | 1.24B | - | 6,465 | 14.84M |
| 329 | HROW | Harrow, Inc. | 1.24B | 1.40% | 824,260 | 268.68M |
| 330 | ENOV | Enovis Corporation | 1.24B | -1.73% | 1,040,779 | 2.28B |
| 331 | TNDM | Tandem Diabetes Care, Inc. | 1.24B | -3.06% | 2,361,510 | 1.03B |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.18B | 2.67% | 2,425,765 | 787.08M |
| 333 | AMN | AMN Healthcare Services, Inc. | 1.18B | 0.20% | 1,309,914 | 3.42B |
| 334 | AVNS | Avanos Medical, Inc. | 1.17B | -0.04% | 2,349,476 | 715.90M |
| 335 | INSP | Inspire Medical Systems, Inc. | 1.17B | -0.34% | 1,140,704 | 915.25M |
| 336 | IRMD | IRADIMED CORPORATION | 1.16B | 1.40% | 112,099 | 86.28M |
| 337 | COAG | Hemab Therapeutics Holdings, Inc. | 1.16B | -4.73% | 210,966 | - |
| 338 | CDNA | CareDx, Inc. | 1.15B | 1.09% | 700,116 | 412.82M |
| 339 | BFLY | Butterfly Network, Inc. | 1.15B | -4.15% | 3,494,072 | 102.92M |
| 340 | PSNL | Personalis, Inc. | 1.13B | -3.23% | 2,907,166 | 64.52M |
| 341 | ARDT | Ardent Health, Inc. | 1.12B | -15.53% | 1,915,160 | 6.43B |
| 342 | SDGR | Schrödinger, Inc. | 1.12B | -0.07% | 1,606,342 | 254.91M |
| 343 | AVLN | Avalyn Pharma Inc. | 1.12B | 3.73% | 206,224 | - |
| 344 | WVE | Wave Life Sciences Ltd. | 1.11B | 1.23% | 2,929,756 | 71.80M |
| 345 | OPK | OPKO Health, Inc. | 1.10B | 4.29% | 4,751,906 | 581.12M |
| 346 | AZTA | Azenta, Inc. | 1.10B | 1.96% | 1,042,516 | 596.48M |
| 347 | KMTS | Kestra Medical Technologies, Ltd. | 1.10B | - | 491,016 | 83.72M |
| 348 | ZBIO | Zenas BioPharma, Inc. | 1.10B | 1.58% | 416,158 | 10.00M |
| 349 | AKTS | Aktis Oncology, Inc. | 1.07B | -4.24% | 268,661 | 8.28M |
| 350 | PNTG | The Pennant Group, Inc. | 1.06B | -1.65% | 386,771 | 1.02B |
| 351 | DBVT | DBV Technologies S.A. | 1.04B | -2.91% | 162,454 | 5.74M |
| 352 | MNKD | MannKind Corporation | 1.04B | -2.04% | 3,494,069 | 360.78M |
| 353 | EVO | Evotec SE | 1.04B | -1.69% | 23,220 | 859.03M |
| 354 | EYPT | EyePoint, Inc. | 1.03B | -1.52% | 835,498 | 7.61M |
| 355 | OMDA | Omada Health, Inc. | 1.03B | -2.59% | 1,107,927 | 283.30M |
| 356 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | -1.83% | 1,162,587 | 314.85M |
| 357 | CRON | Cronos Group Inc. | 1.01B | -0.73% | 1,946,571 | 159.54M |
| 358 | COLL | Collegium Pharmaceutical, Inc. | 1.01B | 1.90% | 473,482 | 796.33M |
| 359 | AORT | Artivion, Inc. | 999.02M | 0.78% | 643,641 | 458.69M |
| 360 | CNMD | CONMED Corporation | 995.41M | -2.33% | 733,095 | 1.37B |
| 361 | ALVO | Alvotech | 982.88M | 4.67% | 637,422 | 562.04M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 975.45M | -0.77% | 1,601,433 | - |
| 363 | INNV | InnovAge Holding Corp. | 961.01M | -1.94% | 246,517 | 949.17M |
| 364 | DRTS | Alpha Tau Medical Ltd. | 954.06M | 18.48% | 3,236,340 | - |
| 365 | GDRX | GoodRx Holdings, Inc. | 951.68M | -4.75% | 1,713,993 | 787.89M |
| 366 | USPH | U.S. Physical Therapy, Inc. | 941.59M | -1.01% | 186,355 | 787.69M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 934.78M | -0.85% | 908,558 | - |
| 368 | QDEL | QuidelOrtho Corporation | 927.40M | 2.33% | 1,820,721 | 2.66B |
| 369 | ABSI | Absci Corporation | 926.08M | -6.46% | 5,122,535 | 1.84M |
| 370 | SPTX | Seaport Therapeutics, Inc. | 921.89M | 1.02% | 91,130 | - |
| 371 | OLMA | Olema Pharmaceuticals, Inc. | 918.02M | -1.68% | 1,449,208 | - |
| 372 | NUTX | Nutex Health Inc. | 914.05M | 6.24% | 150,255 | 879.95M |
| 373 | AVR | Anteris Technologies Global Corp. | 903.76M | -3.66% | 1,061,249 | 1.85M |
| 374 | ANNX | Annexon, Inc. | 883.11M | 2.47% | 2,919,193 | - |
| 375 | PCRX | Pacira BioSciences, Inc. | 878.25M | 0.31% | 223,129 | 734.86M |
| 376 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 1,479,087 | 238.37M |
| 377 | CERT | Certara, Inc. | 871.16M | -0.36% | 3,387,952 | 419.75M |
| 378 | MGTX | MeiraGTx Holdings plc | 869.60M | 1.62% | 492,656 | 79.76M |
| 379 | SPRY | ARS Pharmaceuticals, Inc. | 868.90M | -1.69% | 1,208,915 | 98.99M |
| 380 | SANA | Sana Biotechnology, Inc. | 868.27M | -3.70% | 2,584,879 | - |
| 381 | JBIO | Jade Biosciences, Inc. | 868.24M | -0.90% | 550,733 | - |
| 382 | PHAR | Pharming Group N.V. | 866.52M | 0.90% | 4,427 | 369.49M |
| 383 | SSII | SS Innovations International, Inc. | 861.74M | 7.48% | 123,013 | 48.47M |
| 384 | ABUS | Arbutus Biopharma Corporation | 859.29M | 2.11% | 1,728,756 | 191.45M |
| 385 | INMD | InMode Ltd. | 854.71M | -0.07% | 731,911 | 374.64M |
| 386 | XNCR | Xencor, Inc. | 846.70M | 1.87% | 602,542 | 97.36M |
| 387 | JANX | Janux Therapeutics, Inc. | 828.78M | -1.38% | 688,508 | 13.73M |
| 388 | REPL | Replimune Group, Inc. | 824.07M | 12.51% | 8,994,910 | - |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 821.76M | -2.12% | 2,655,255 | 69.64M |
| 390 | TBPH | Theravance Biopharma, Inc. | 820.21M | 2.12% | 334,985 | 109.78M |
| 391 | IVA | Inventiva S.A. | 817.33M | -1.22% | 1,251,026 | 7.94M |
| 392 | ORIC | ORIC Pharmaceuticals, Inc. | 811.58M | 2.89% | 2,116,263 | - |
| 393 | ESPR | Esperion Therapeutics, Inc. | 808.34M | - | 25,104,060 | 418.24M |
| 394 | LBRX | LB Pharmaceuticals Inc | 801.51M | 3.44% | 198,406 | - |
| 395 | PHAT | Phathom Pharmaceuticals, Inc. | 801.45M | 4.56% | 2,037,312 | 204.89M |
| 396 | AMPH | Amphastar Pharmaceuticals, Inc. | 798.96M | -1.79% | 509,269 | 720.53M |
| 397 | OCS | Oculis Holding AG | 793.50M | 6.92% | 1,675,225 | 1.40M |
| 398 | ODTX | Odyssey Therapeutics, Inc. | 787.34M | -1.42% | 365,105 | 2.98M |
| 399 | KURA | Kura Oncology, Inc. | 768.34M | -3.51% | 1,587,695 | 71.64M |
| 400 | AURA | Aura Biosciences, Inc. | 758.86M | -0.29% | 253,012 | - |
| 401 | ETON | Eton Pharmaceuticals, Inc. | 756.30M | 0.77% | 331,860 | 86.93M |
| 402 | DRUG | Bright Minds Biosciences Inc. | 749.19M | -3.07% | 761,390 | - |
| 403 | LMRI | Lumexa Imaging Holdings, Inc. | 746.55M | 3.46% | 762,379 | 1.03B |
| 404 | GERN | Geron Corporation | 744.16M | -0.85% | 10,088,139 | 196.12M |
| 405 | OMER | Omeros Corporation | 735.33M | -0.97% | 1,848,906 | 9.89M |
| 406 | VOR | Vor Biopharma Inc. | 728.26M | -1.61% | 655,684 | - |
| 407 | AVTX | Avalo Therapeutics, Inc. | 722.25M | -1.58% | 2,515,360 | 59.00K |
| 408 | HSTM | HealthStream, Inc. | 716.94M | -2.70% | 274,199 | 311.78M |
| 409 | BVS | Bioventus Inc. | 714.22M | 5.43% | 1,362,395 | 576.30M |
| 410 | BIOA | BioAge Labs, Inc. | 713.02M | -3.02% | 256,662 | 10.32M |
| 411 | EVMN | Evommune, Inc. | 710.64M | -0.45% | 272,116 | 10.00M |
| 412 | CTMX | CytomX Therapeutics, Inc. | 701.00M | 1.90% | 3,542,142 | 35.54M |
| 413 | ALLO | Allogene Therapeutics, Inc. | 690.31M | -2.44% | 9,057,142 | 22.00K |
| 414 | SLDB | Solid Biosciences Inc. | 674.38M | 4.10% | 918,233 | - |
| 415 | RLMD | Relmada Therapeutics, Inc. | 663.96M | -1.40% | 797,606 | - |
| 416 | ANRO | Alto Neuroscience, Inc. | 660.74M | 0.75% | 471,500 | - |
| 417 | DSGN | Design Therapeutics, Inc. | 652.05M | 2.65% | 632,772 | - |
| 418 | CBLL | CeriBell, Inc. | 651.86M | -1.83% | 348,377 | 95.07M |
| 419 | ZVRA | Zevra Therapeutics, Inc. | 647.90M | 0.74% | 1,582,749 | 122.29M |
| 420 | CRMD | CorMedix Inc. | 645.66M | 0.73% | 835,831 | 400.05M |
| 421 | CADL | Candel Therapeutics, Inc. | 644.78M | 4.51% | 2,140,628 | - |
| 422 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 643.26M | -2.90% | 174,616 | - |
| 423 | TENX | Tenax Therapeutics, Inc. | 634.12M | -1.64% | 554,233 | - |
| 424 | SGP | SpyGlass Pharma, Inc. | 620.40M | 2.18% | 47,138 | - |
| 425 | CSTL | Castle Biosciences, Inc. | 618.43M | 3.45% | 516,575 | 339.92M |
| 426 | SIBN | SI-BONE, Inc. | 617.34M | -0.64% | 561,062 | 206.22M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 617.31M | -4.54% | 1,578,402 | 8.37M |
| 428 | TLRY | Tilray Brands, Inc. | 609.54M | -5.02% | 3,683,721 | 858.28M |
| 429 | CBIO | Crescent Biopharma, Inc. | 597.46M | 5.73% | 146,804 | 11.88M |
| 430 | PHR | Phreesia, Inc. | 596.48M | -6.85% | 1,498,142 | 495.59M |
| 431 | AGMB | AgomAb Therapeutics NV | 590.98M | 1.69% | 88,208 | - |
| 432 | IMMX | Immix Biopharma, Inc. | 589.03M | 0.84% | 1,051,687 | - |
| 433 | CABA | Cabaletta Bio, Inc. | 583.74M | -2.72% | 4,631,721 | - |
| 434 | DNA | Ginkgo Bioworks Holdings, Inc. | 570.28M | -6.43% | 1,343,420 | 151.40M |
| 435 | PRME | Prime Medicine, Inc. | 567.14M | -2.18% | 3,372,365 | 4.03M |
| 436 | BWAY | BrainsWay Ltd. | 563.12M | -3.57% | 163,233 | 56.22M |
| 437 | RIGL | Rigel Pharmaceuticals, Inc. | 560.61M | 0.93% | 422,195 | 299.77M |
| 438 | ALT | Altimmune, Inc. | 558.14M | -1.03% | 3,011,874 | 36.00K |
| 439 | BBNX | Beta Bionics, Inc. | 554.79M | -2.66% | 1,045,775 | 110.24M |
| 440 | TCMD | Tactile Systems Technology, Inc. | 549.70M | -0.16% | 291,313 | 343.52M |
| 441 | NPCE | NeuroPace, Inc. | 541.41M | -2.52% | 177,058 | 99.53M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 539.66M | 4.27% | 130,953 | - |
| 443 | MDXG | MiMedx Group, Inc. | 537.69M | 1.12% | 1,297,456 | 389.42M |
| 444 | SRTA | Strata Critical Medical, Inc. | 537.33M | -0.80% | 722,864 | 228.58M |
| 445 | TRAX | First Tracks Biotherapeutics, Inc. | 534.55M | -5.08% | 545,014 | - |
| 446 | IRWD | Ironwood Pharmaceuticals, Inc. | 533.35M | -1.22% | 2,684,274 | 361.51M |
| 447 | CERS | Cerus Corporation | 532.98M | -1.48% | 2,183,627 | 216.56M |
| 448 | VALN | Valneva SE | 523.48M | -0.89% | 15,323 | 180.25M |
| 449 | CTKB | Cytek Biosciences, Inc. | 523.03M | -3.34% | 705,691 | 204.17M |
| 450 | XOMA | XOMA Royalty Corporation | 522.96M | 0.02% | 67,789 | 48.56M |
| 451 | PROK | ProKidney Corp. | 522.56M | -8.95% | 837,849 | 889.00K |
| 452 | GYRE | Gyre Therapeutics, Inc. | 519.91M | 2.70% | 72,128 | 117.05M |
| 453 | FLGT | Fulgent Genetics, Inc. | 515.76M | -2.89% | 708,271 | 320.35M |
| 454 | EIKN | Eikon Therapeutics, Inc. | 510.53M | -1.77% | 353,792 | - |
| 455 | AQST | Aquestive Therapeutics, Inc. | 505.56M | 2.54% | 1,698,279 | 50.27M |
| 456 | ACHV | Achieve Life Sciences, Inc. | 505.08M | -2.19% | 1,360,917 | - |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 458 | CLYM | Climb Bio, Inc. | 498.70M | -6.79% | 1,299,969 | - |
| 459 | FDMT | 4D Molecular Therapeutics, Inc. | 498.19M | 2.80% | 948,557 | 88.24M |
| 460 | ARVN | Arvinas, Inc. | 496.81M | -3.75% | 1,270,921 | 89.40M |
| 461 | PACB | Pacific Biosciences of California, Inc. | 490.75M | - | 6,841,133 | 160.03M |
| 462 | ASMB | Assembly Biosciences, Inc. | 486.91M | 0.33% | 180,834 | 71.10M |
| 463 | RZLT | Rezolute, Inc. | 478.46M | 14.50% | 5,234,963 | - |
| 464 | KYTX | Kyverna Therapeutics, Inc. | 473.35M | -1.01% | 816,254 | - |
| 465 | CTNM | Contineum Therapeutics, Inc. | 467.89M | 1.09% | 434,324 | - |
| 466 | PRTA | Prothena Corporation plc | 466.99M | -2.94% | 592,877 | 57.94M |
| 467 | ANGO | AngioDynamics, Inc. | 466.84M | 2.00% | 294,785 | 313.73M |
| 468 | MOBI | Mobia Medical, Inc. | 454.26M | -0.36% | 353,717 | 32.04M |
| 469 | WEAV | Weave Communications, Inc. | 451.93M | -5.80% | 935,639 | 248.72M |
| 470 | ANL | Adlai Nortye Ltd. | 450.40M | -2.76% | 229,766 | 5.00M |
| 471 | STRO | Sutro Biopharma, Inc. | 450.38M | 11.26% | 435,262 | 99.61M |
| 472 | CTEV | Claritev Corporation | 447.85M | -7.30% | 110,059 | 978.76M |
| 473 | OVID | Ovid Therapeutics Inc. | 446.07M | -0.42% | 2,142,725 | 7.12M |
| 474 | LAB | Standard BioTools Inc. | 445.02M | -1.72% | 3,613,012 | 86.26M |
| 475 | OCGN | Ocugen, Inc. | 440.08M | -2.99% | 4,432,414 | 4.47M |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.96M | -4.81% | 292,061 | - |
| 477 | CCCC | C4 Therapeutics, Inc. | 436.32M | -8.76% | 1,992,184 | 34.86M |
| 478 | KIDS | OrthoPediatrics Corp. | 434.59M | 0.65% | 189,566 | 243.30M |
| 479 | AUTL | Autolus Therapeutics plc | 431.15M | -7.43% | 2,063,868 | 92.62M |
| 480 | NRC | NRC Health | 428.65M | -2.91% | 167,498 | 138.64M |
| 481 | VREX | Varex Imaging Corporation | 428.00M | 2.16% | 810,886 | 857.50M |
| 482 | KMDA | Kamada Ltd. | 427.08M | -1.60% | 59,650 | 181.68M |
| 483 | EDIT | Editas Medicine, Inc. | 426.62M | -1.42% | 3,205,462 | 38.69M |
| 484 | CNXU | Conexeu Sciences Inc. | 425.80M | 0.06% | 154,337 | - |
| 485 | EVH | Evolent Health, Inc. | 425.18M | -4.55% | 3,074,100 | 1.89B |
| 486 | SGMT | Sagimet Biosciences Inc. | 423.62M | 1.03% | 662,289 | - |
| 487 | TOI | The Oncology Institute, Inc. | 422.93M | -7.84% | 1,340,187 | 545.76M |
| 488 | MYGN | Myriad Genetics, Inc. | 415.57M | 2.09% | 1,982,333 | 829.00M |
| 489 | FBRX | Forte Biosciences, Inc. | 415.41M | -6.49% | 354,630 | - |
| 490 | UPB | Upstream Bio, Inc. | 415.22M | 5.24% | 666,442 | 3.32M |
| 491 | NGNE | Neurogene Inc. | 414.33M | 0.31% | 87,586 | 925.00K |
| 492 | EBS | Emergent BioSolutions Inc. | 409.16M | -3.41% | 1,041,997 | 676.80M |
| 493 | VTVT | vTv Therapeutics Inc. | 409.02M | -0.12% | 22,693 | 36.84M |
| 494 | CCRN | Cross Country Healthcare, Inc. | 406.83M | 0.23% | 283,335 | 1.00B |
| 495 | CATX | Perspective Therapeutics, Inc. | 406.00M | -1.11% | 979,715 | 618.00K |
| 496 | MNPR | Monopar Therapeutics Inc. | 405.68M | -1.18% | 72,825 | - |
| 497 | CLPT | ClearPoint Neuro, Inc. | 398.86M | 7.52% | 742,473 | 40.61M |
| 498 | EOLS | Evolus, Inc. | 397.10M | -2.27% | 496,865 | 301.79M |
| 499 | OFIX | Orthofix Medical Inc. | 392.90M | 0.10% | 678,396 | 825.37M |
| 500 | CGC | Canopy Growth Corporation | 392.27M | -1.89% | 5,934,760 | 203.04M |